Investment Rating - The report maintains a "Buy" rating for the company [3][6] Core Views - The company demonstrated steady revenue growth with a 2025 revenue of 31.714 billion RMB, up 4.6% year-on-year, and a net profit of 2.050 billion RMB, up 10.9% year-on-year. The second half of 2025 saw a slight decline in revenue and net profit [1][3] - The food segment achieved a revenue of 10.494 billion RMB, a 5.0% increase year-on-year, with a significant profit increase of 40.1% to 379 million RMB, indicating a focus on health and quality [1] - The beverage segment reported a revenue of 19.4 billion RMB, a 1.2% increase year-on-year, with notable performance in tea and milk tea categories [2] - The company is expected to maintain a high dividend policy, with projected net profits for 2026-2028 of 2.200 billion RMB, 2.361 billion RMB, and 2.522 billion RMB, respectively [3] Financial Summary - In 2025, the company achieved a gross margin of 33.20%, an increase of 0.66 percentage points year-on-year, with the beverage segment achieving a gross margin of 37.8% [2] - The company’s net profit margin reached 6.46%, up 0.37 percentage points year-on-year, with a reduction in selling and administrative expense ratios [2] - The projected earnings per share (EPS) for 2026 is 0.51 RMB, with a steady increase expected in subsequent years [5]
统一企业中国（00220）：业绩增长稳健，股息优势突出